Sign In

Credits Offered

  • Continuing Medical Education (CME): 10.50 AMA PRA Category 1 Credits

Accreditation and Designation Statements

Continuing Medical Education (CME)
The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AASLD designates this live activity for a maximum of 10.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Claiming CME Credits

Physicians and other health care professionals seeking AMA PRA Category 1 Credits™ for this live continuing medical education activity must complete an evaluation by Friday, March 1, 2019. A link to the CME evaluation will be emailed to attendees after the meeting.

Needs Statement

The goal of the conference is to promote global elimination of hepatitis C infection. World leaders in the related disciplines will assemble to establish the current state of the science and public health challenges. The experts will then formulate the most effective future steps toward elimination.

Learning Objectives

Upon completion of this activity, learners will be able to:

  • Describe the major obstacles to global elimination of HCV infection;
  • Identify measures that are likely to reduce the burden of disease;
  • Compare the historic successes to the future needs.

Target Audience

  • Hepatologists
  • Gastroenterologists
  • Infectious Diseases Physicians
  • Public Health Workers

This activity was planned in the context of the following ACGME / IOM / IPEC competencies: Medical Knowledge; Work in Interdisciplinary Teams; Apply Quality Improvement; Values/Ethics for Interpersonal Practice; Roles/Responsibilities; and Teams and Teamwork.